ID

35198

Beskrivning

Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the subjects laboratory tests and should be filled out at Visit 1, 6 (liver tests only) , 8, EW, Day 7 Follow Up, Day 14 Follow Up. Laboratory tests are mandatory at Day 7 FU visit except where Day 7 FU follows Early Withdrawal Visit.

Länk

https://clinicaltrials.gov/ct2/show/NCT00992160

Nyckelord

Versioner (2)

1. 2019-02-24 2019-02-24 -
2. 2019-11-10 2019-11-10 -

Rättsinnehavare

GlaxoSmithKline

Uppladdad den

24 februari 2019

DOI

För en begäran logga in.

Licens